Recall events
/
Event 72102
Event summary
Timeline bucket August 21, 2015
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording Nephron Pharmaceuticals Corp.
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
2 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 2
Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator, Starter Kit (Racepinephrine 11.25 mg) 10 individual foil wrapped vials with 1 EZ Breathe Atomizer per carton, Manufactured By: nephron pharmaceuticals corporation, Orlando, FL --- NDC 0487-2784-10
D-0388-2016
Recall number D-0388-2016
Initiated August 21, 2015
Classification Class II
Status Terminated
Quantity 47,754 cartons
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Discoloration
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Discoloration
Code information Lots R4027A (Exp 10/31/2015), R4036A (Exp 12/31/2015)
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2605]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 2
Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator Refills (Racepinephrine USP 11.25 mg), 30 individual foil wrapped vials per carton, Manufactured By: nephron pharmaceuticals corporation, Orlando, FL --- NDC 0487-2784-01
D-0389-2016
Recall number D-0389-2016
Initiated August 21, 2015
Classification Class II
Status Terminated
Quantity 32,490 cartons
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Discoloration
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Discoloration
Code information Lots R4016A (Exp 08/31/2015), R4017A (Exp 08/31/2015), R4035A (Exp 12/31/2015)
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[16172]
FDA event record
· Exact recall-number query on openFDA